{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:29:30Z","timestamp":1791602970403,"version":"4.3.4"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Asthma control during pregnancy is critical to prevent maternal and perinatal complications. Although guidelines recommend continuing inhaled corticosteroids (ICSs), discontinuation is common and clinical evidence of major maternal and neonatal outcomes limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the association between ICS continuation during the first trimester of pregnancy and maternal and neonatal outcomes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nationwide, population-based cohort study used a mother-child linked health care database (January 1, 2009, to December 31, 2023) and included live births in Korea between April 1, 2010, and December 31, 2022. Women (aged 15-50 years) with asthma who received at least 2 ICS prescriptions in the 6 months before their last menstrual period were identified to increase the likelihood that prescription records reflected ongoing ICS use. Data were analyzed from April 28 to November 10, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Women classified as ICS continuers (\u22651 ICS prescription during the first trimester) or discontinuers (no prescription during the same period).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Maternal outcomes included preeclampsia, gestational diabetes, obstructed labor, antepartum hemorrhage, premature rupture of membranes, and preterm birth; neonatal outcomes included hypoxia or asphyxia, low birth weight, and congenital malformations. Propensity score overlap-weighted log-binomial regression models were used to estimate risk ratios (RRs) and 95% CIs for each maternal and neonatal outcome.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 3 909 084 pregnancies, 6105 involved prepregnancy ICS use for asthma. A total of 2108 women (34.5%; mean [SD] age, 33.2 [4.4] years) continued ICS in the first trimester, and 3997 women (65.5%; mean [SD] age, 32.9 [4.2] years) discontinued use. Risks per 1000 pregnancies for ICS continuation vs discontinuation, respectively, were as follows: gestational diabetes, 145.6 vs 131.9 (weighted RR, 1.05; 95% CI, 0.90-1.22); preterm birth, 131.4 vs 128.6 (weighted RR, 0.95; 95% CI, 0.82-1.11); low birth weight, 77.5 vs 58.3 (weighted RR, 1.11; 95% CI, 0.89-1.39); and congenital malformations, 57.6 vs 42.2 (weighted RR, 1.22; 95% CI, 0.94-1.56). Continuation of ICSs was not associated with increased risks of these or other maternal and neonatal outcomes.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This nationwide cohort study found that continued ICS use during early pregnancy was not associated with increased risks of maternal or neonatal outcomes, despite frequent discontinuation. These findings provide reassuring evidence supporting current guideline recommendations to continue ICS therapy during pregnancy and highlight the importance of individualized risk assessment while maintaining asthma control.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.30781","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:43:18Z","timestamp":1787586198000},"page":"e2630781","source":"Crossref","is-referenced-by-count":1,"title":["Inhaled Corticosteroids Continuation in the First Trimester and Pregnancy Outcomes in Women With Asthma"],"prefix":"10.1001","volume":"9","author":[{"given":"Bohyun","family":"Suh","sequence":"first","affiliation":[{"name":"Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Cho","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Choi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea"},{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Division of Allergy and Clinical Immunology, Seoul National University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom"},{"name":"Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea"},{"name":"School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea"},{"name":"Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunha","family":"Noh","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chonnam National University, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"3","key":"zoi260844r1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1300\/J013v29n03_03","article-title":"The relationship between asthma and smoking during pregnancy.","volume":"29","author":"Kurinczuk","year":"1999","journal-title":"Women Health"},{"issue":"2","key":"zoi260844r2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/thx.2005.049718","article-title":"Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.","volume":"61","author":"Murphy","year":"2006","journal-title":"Thorax"},{"issue":"4","key":"zoi260844r3","doi-asserted-by":"publisher","first-page":"00295","DOI":"10.1183\/23120541.00295-2020","article-title":"Effect of maternal asthma exacerbations on perinatal outcomes: a population-based study.","volume":"6","author":"Robijn","year":"2020","journal-title":"ERJ Open Res"},{"issue":"1","key":"zoi260844r5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2500\/aap.2023.44.220077","article-title":"Asthma in pregnancy.","volume":"44","author":"Bravo-Solarte","year":"2023","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"zoi260844r6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajog.2006.01.065","article-title":"Cessation of asthma medication in early pregnancy.","volume":"195","author":"Enriquez","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"zoi260844r7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/cea.13474","article-title":"Inhaled corticosteroid use during pregnancy among women with asthma: a systematic review and meta-analysis.","volume":"49","author":"Robijn","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"zoi260844r8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1081-1206(10)61219-7","article-title":"Inhaled corticosteroid use and outcomes in pregnancy.","volume":"95","author":"Schatz","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"zoi260844r9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104755","article-title":"Asthma during pregnancy in a population-based study\u2013pregnancy complications and adverse perinatal outcomes.","volume":"9","author":"Rejn\u00f6","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"zoi260844r10","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1080\/02770903.2022.2155185","article-title":"Beliefs about medicines and adherence to asthma medications during pregnancy.","volume":"60","author":"Murphy","year":"2023","journal-title":"J Asthma"},{"issue":"10","key":"zoi260844r11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3109\/02770903.2011.631239","article-title":"Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.","volume":"48","author":"Powell","year":"2011","journal-title":"J Asthma"},{"issue":"6","key":"zoi260844r12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/02770903.2018.1471709","article-title":"Trends in asthma self-management skills and inhaled corticosteroid use during pregnancy and postpartum from 2004 to 2017.","volume":"56","author":"Robijn","year":"2019","journal-title":"J Asthma"},{"issue":"6","key":"zoi260844r13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jaip.2024.02.017","article-title":"Impact of asthma medications during pregnancy on asthma exacerbation, maternal, and neonatal outcomes.","volume":"12","author":"Lee","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"zoi260844r14","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.jaip.2020.01.016","article-title":"Perinatal outcomes associated with maternal asthma and its severity and control during pregnancy.","volume":"8","author":"Yland","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"zoi260844r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242489","article-title":"Medicines prescribed for asthma, discontinuation and perinatal outcomes, including breastfeeding: a population cohort analysis.","volume":"15","author":"Davies","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"zoi260844r16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jaci.2007.05.044","article-title":"Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes.","volume":"120","author":"Enriquez","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"zoi260844r17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.rmed.2016.10.004","article-title":"Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: a case control study.","volume":"120","author":"Ali","year":"2016","journal-title":"Respir Med"},{"issue":"7","key":"zoi260844r18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/thoraxjnl-2014-206634","article-title":"Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.","volume":"70","author":"Blais","year":"2015","journal-title":"Thorax"},{"issue":"8","key":"zoi260844r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104755","article-title":"Asthma during pregnancy in a population-based study\u2014pregnancy complications and adverse perinatal outcomes.","volume":"9","author":"Rejn\u00f6","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"zoi260844r20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1081-1206(10)60201-3","article-title":"Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth.","volume":"101","author":"Bakhireva","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"zoi260844r21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/j.1875-9114.2012.01091.x","article-title":"Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy.","volume":"32","author":"Blais","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"1","key":"zoi260844r22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases.","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"zoi260844r23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi260844r24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/pds.2217","article-title":"Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy.","volume":"20","author":"Andrade","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"zoi260844r27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients.","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"13","key":"zoi260844r28","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/1471-0528.13254","article-title":"Validation of an obstetric comorbidity index in an external population.","volume":"122","author":"Metcalfe","year":"2015","journal-title":"BJOG"},{"issue":"25","key":"zoi260844r29","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"zoi260844r30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwy201","article-title":"Addressing extreme propensity scores via the overlap weights.","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"zoi260844r31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8276190","article-title":"Effect of pregnancy on quantitative medication use and relation to exacerbations in asthma.","volume":"2017","author":"Koo","year":"2017","journal-title":"Biomed Res Int"},{"issue":"6","key":"zoi260844r32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01327-2025","article-title":"Pregnancy, asthma and exacerbations: a population-based cohort.","volume":"66","author":"Lee","year":"2025","journal-title":"Eur Respir J"},{"key":"zoi260844r33","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1055\/a-2097-1468","article-title":"The association of periconception asthma medication discontinuation with adverse obstetric outcomes.","volume":"41","author":"Rohn","year":"2024","journal-title":"Am J Perinatol"},{"issue":"8","key":"zoi260844r34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1191\/0960327106het647oa","article-title":"Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review.","volume":"25","author":"Rahimi","year":"2006","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"zoi260844r35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/02770903.2020.1847934","article-title":"Exacerbations of asthma following step-up and step-down inhaled corticosteroid and long acting beta agonist therapy in the managing asthma in pregnancy study.","volume":"59","author":"Murphy","year":"2022","journal-title":"J Asthma"},{"issue":"1","key":"zoi260844r36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2515\/therapie\/2014003","article-title":"Teratogenic mechanisms associated with prenatal medication exposure.","volume":"69","author":"van Gelder","year":"2014","journal-title":"Therapie"},{"issue":"5","key":"zoi260844r37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/02770903.2012.678024","article-title":"Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma.","volume":"49","author":"Lim","year":"2012","journal-title":"J Asthma"},{"issue":"6","key":"zoi260844r38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1157\/13112989","article-title":"Pregnancy outcomes in women using inhaled fluticasone during pregnancy: a case series.","volume":"35","author":"Choi","year":"2007","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"zoi260844r39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/cpt.3598","article-title":"Modern evidence generation on medication effectiveness and safety during pregnancy: study design considerations.","volume":"117","author":"Huybrechts","year":"2025","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"zoi260844r40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1183\/20734735.007915","article-title":"Managing asthma in pregnancy.","volume":"11","author":"Murphy","year":"2015","journal-title":"Breathe (Sheff)"},{"issue":"4","key":"zoi260844r41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jaci.2010.08.018","article-title":"Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy.","volume":"126","author":"Breton","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"zoi260844r42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients.","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"key":"zoi260844r25","volume-title":"EUROCAT Guide 1.5 Instruction for the Registration of Congenital Anomalies. EUROCAT Central Registry","author":"EUROCAT","year":"2025"},{"key":"zoi260844r4","unstructured":"Homepage. Global Initiative for Asthma. Accessed May 20, 2025. https:\/\/ginasthma.org\/"},{"key":"zoi260844r26","unstructured":"European Platform on Rare Disease Registration. European Commission. Accessed August 8, 2025. https:\/\/eu-rd-platform.jrc.ec.europa.eu"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853205\/suh_2026_oi_260844_1791293788.18014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:00:19Z","timestamp":1791558019000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.30781","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}